TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

Restaging cancer can be an unfamiliar space, but with more experience, APPs can rely less on MDs for guidance in such cases.

Experts discuss the patient case of Janet, a 58-year-old with her 2 positive metastatic breast cancer, and after 14 months on ...

Oncology nurses and APPs provide support and can help to facilitate conversations with patients and families during end-of-life care.

Patients with recurrent/metastatic HER2-positive breast cancer experienced durable response and manageable safety from ...

In myeloma treatment, acute CRS is a common but treatable AE associated with CAR T-cell therapy and bispecific antibodies, according to a nurse practitioner. When treating with CAR T-cell therapies ...

The FDA has approved treatment with pembrolizumab plus trastuzumab and chemotherapy for HER2+ gastric/GEJ adenocarcinoma with PD-L1 CPS of 1 or greater. The FDA has granted traditional approval to ...

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality and similar quality of life to usual care. A shared care model after ...